JMP Securities Upgrades Optimer Pharmaceuticals (OPTR) to Market Outperform, Price Target $16
Tweet Send to a Friend
JMP Securities upgraded Optimer Pharmaceuticals (NASDAQ: OPTR) to a Market Outperform rating from its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
